Resona Asset Management Co. Ltd. Invests $6.46 Million in Astera Labs, Inc. $ALAB

Resona Asset Management Co. Ltd. purchased a new position in Astera Labs, Inc. (NASDAQ:ALABFree Report) in the 4th quarter, Holdings Channel reports. The firm purchased 38,728 shares of the company’s stock, valued at approximately $6,463,000.

Several other hedge funds have also recently modified their holdings of ALAB. Vanguard Group Inc. raised its stake in shares of Astera Labs by 14.1% in the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock worth $2,690,907,000 after purchasing an additional 1,693,918 shares during the last quarter. Amundi raised its stake in shares of Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC purchased a new position in shares of Astera Labs in the third quarter worth $209,599,000. BNP Paribas Financial Markets raised its stake in shares of Astera Labs by 577.3% in the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after purchasing an additional 960,899 shares during the last quarter. Finally, Voloridge Investment Management LLC purchased a new position in shares of Astera Labs in the third quarter worth $131,539,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Trading Up 3.0%

Shares of ALAB opened at $306.88 on Friday. The firm has a market cap of $52.60 billion, a PE ratio of 207.35, a P/E/G ratio of 3.94 and a beta of 3.35. The firm has a fifty day simple moving average of $170.39 and a two-hundred day simple moving average of $159.79. Astera Labs, Inc. has a 1-year low of $84.78 and a 1-year high of $315.81.

Astera Labs (NASDAQ:ALABGet Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The company’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the company. Citigroup boosted their price target on Astera Labs from $200.00 to $245.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday. Loop Capital initiated coverage on shares of Astera Labs in a research note on Thursday, March 5th. They set a “buy” rating and a $250.00 target price for the company. Rothschild & Co Redburn initiated coverage on shares of Astera Labs in a research note on Friday, May 1st. They set a “neutral” rating and a $153.00 target price for the company. Finally, Susquehanna boosted their target price on shares of Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and an average target price of $233.75.

View Our Latest Stock Analysis on Astera Labs

Insider Buying and Selling

In other news, CEO Jitendra Mohan sold 28,737 shares of the company’s stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $249.62, for a total value of $7,173,329.94. Following the completion of the sale, the chief executive officer directly owned 3,789,232 shares in the company, valued at $945,868,091.84. This represents a 0.75% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 280,000 shares of the company’s stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $249.19, for a total value of $69,773,200.00. Following the completion of the sale, the chief operating officer owned 615,000 shares of the company’s stock, valued at $153,251,850. This trade represents a 31.28% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 1,915,461 shares of company stock valued at $358,508,976. Company insiders own 12.50% of the company’s stock.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Evercore ISI raised its price target on Astera Labs to $297 from $215 and kept an Outperform rating after updated AI channel checks, reinforcing the market’s view that ALAB is benefiting from strong AI infrastructure demand. Article Title
  • Positive Sentiment: Multiple reports point to momentum from the AI inference boom, with traders and investors buying into the stock after bullish coverage, elevated call activity, and a “golden cross” technical breakout that can attract trend-following buyers. Article Title
  • Positive Sentiment: Recent commentary highlighted Astera Labs as a beneficiary of rising AI infrastructure spending, supporting the stock’s move higher and helping it reach fresh highs. Article Title
  • Neutral Sentiment: Executives including the CEO, COO, and general counsel disclosed large share sales, but several transactions were tied to pre-arranged 10b5-1 plans or tax withholding on equity awards, which makes the selling less conclusive as a bearish signal. Article Title

Astera Labs Company Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.